Albendazole induces immunotherapy response by facilitating ubiquitin-mediated PD-L1 degradation.
J Immunother Cancer. 2022 May;10(5):e003819. doi: 10.1136/jitc-2021-003819.
J Immunother Cancer. 2022.
PMID: 35577504
Free PMC article.